« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

What are the ABCDEs of melanoma?

Classic malignant melanoma demonstrating asymmetry, irregular notched border, multiple colors, wide diameter, and a history of change and growth (evolution).
Fig. 45.1 Classic malignant melanoma demonstrating asymmetry, irregular notched border, multiple colors, wide diameter, and a history of change and growth (evolution).
The development of a new or changing pigmented lesion is the classic initial presentation of melanoma. A lesion that demonstrates a noticeable increase in size over a period of weeks to months or development of pigment irregularity (black, hues of brown, red, blue, or white) should be evaluated by a physician and biopsied. The ABCDEs of melanoma (Fig. 45-1) are a helpful guideline for determining which moles could be suspicious for
  • Asymmetry. Any mole that appears unusual or shows asymmetry in shape should be evaluated.
  • Border and bleeding. The border of any melanocytic nevus should be relatively smooth, with a clear demarcation between the nevus and surrounding normal skin. Nevi that develop irregular or ill-defined borders should be evaluated. B is also for bleeding, and any mole that bleeds needs careful evaluation.
  • Color. Most moles have a homogeneous tan or brown color. Moles that develop pigment variegation within an otherwise homogeneous background should be evaluated.
  • Diameter. Most melanomas are 0.6 mm in diameter, but an otherwise suspicious lesion that is small might also be malignant.
  • Evolving. This emphasizes the need to evaluate any melanocytic nevus is whether the nevus has changed in terms of the ABCDs over a relatively short time (weeks to months).
It should be stressed that the ABCDEs are meant strictly as guidelines and cannot take the place of a thorough evaluation. Some physicians stress utilizing the “ugly duckling” sign. The latter refers to the fact that nevi in an individual generally tend to share a similar appearance, so one that does not share the same characteristics should be considered for biopsy.

Abbasi NR, Shaw HM, Rigel DS, et al: Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria, JAMA 292:2771–2776, 2004.